Cargando…
A novel Danshensu/tetramethylpyrazine protects against Myocardial Ischemia Reperfusion Injury in rats
A new Danshensu/tetramethylpyrazine derivative (ADTM) with cardio-protection effects such as antioxidant, arterial relaxation, pro-angiogenesis and antiplatelet activities. Platelet activating factor receptor (PAFR) plays a key role in myocardial ischemia reperfusion (MIR) injury. This study aims to...
Autores principales: | Wang, Jinghao, Fan, Kai, He, Cong, Wang, Qingyang, Zhang, Qianhui, Huang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176181/ https://www.ncbi.nlm.nih.gov/pubmed/34104104 http://dx.doi.org/10.7150/ijms.59411 |
Ejemplares similares
-
Protective Effect of Tetramethylpyrazine on Myocardial Ischemia-Reperfusion Injury
por: Qian, Weidong, et al.
Publicado: (2014) -
Ultrasound-Enhanced Protective Effect of Tetramethylpyrazine against Cerebral Ischemia/Reperfusion Injury
por: Zhang, Chunbing, et al.
Publicado: (2014) -
Synergistic neuroprotective effects of Danshensu and hydroxysafflor yellow A on cerebral ischemia-reperfusion injury in rats
por: Xu, Hang, et al.
Publicado: (2017) -
Sodium danshensu attenuates cerebral ischemia–reperfusion injury by targeting AKT1
por: Gao, Qing, et al.
Publicado: (2022) -
A Danshensu-Tetramethylpyrazine Conjugate DT-010 Overcomes Multidrug Resistance in Human Breast Cancer
por: Zhou, Xinhua, et al.
Publicado: (2019)